Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
In the media 1 Aug 2026 End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment Daily Nation
In the media 30 Jul 2026 WHO approves new shorter, less painful Kala-azar treatment for East Africa New Vision
Viewpoints 30 Jul 2026 Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases Stat News
In the media 21 Jul 2026 How Scientists Can Revive Global Health Drug Development Think Global Health
In the media 15 Jul 2026 Dengue outbreak complicates Bangladesh measles crisis response The Telegraph
Press releases 13 Jul 2026 DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security
Press releases 13 Jul 2026 DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals
News 17 Jun 2026 DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines
News 2 Feb 2026 Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
News 30 Jan 2026 Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases
News 27 Jan 2026 DNDi and APHRC sign MoU to forge strategic alliance to bridge research and capacity enhancement gaps
